"Insulin Infusion Systems" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Portable or implantable devices for infusion of insulin. Includes open-loop systems which may be patient-operated or controlled by a pre-set program and are designed for constant delivery of small quantities of insulin, increased during food ingestion, and closed-loop systems which deliver quantities of insulin automatically based on an electronic glucose sensor.
| Descriptor ID |
D007332
|
| MeSH Number(s) |
E02.319.300.508 E07.505.508 E07.858.082.505.508
|
| Concept/Terms |
Insulin Infusion Systems- Insulin Infusion Systems
- Infusion System, Insulin
- Infusion Systems, Insulin
- Insulin Infusion System
- System, Insulin Infusion
- Systems, Insulin Infusion
Implantable Programmable Insulin Pump- Implantable Programmable Insulin Pump
- Programmable Implantable Insulin Pump
- Pump, Programmable Implantable Insulin
- Insulin Pump, Programmable Implantable
beta Cell, Artificial- beta Cell, Artificial
- Artificial beta Cell
- Artificial beta Cells
- Cell, Artificial beta
- Cells, Artificial beta
- beta Cells, Artificial
|
Below are MeSH descriptors whose meaning is more general than "Insulin Infusion Systems".
Below are MeSH descriptors whose meaning is more specific than "Insulin Infusion Systems".
This graph shows the total number of publications written about "Insulin Infusion Systems" by people in this website by year, and whether "Insulin Infusion Systems" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2005 | 2 | 1 | 3 |
| 2006 | 1 | 0 | 1 |
| 2008 | 2 | 1 | 3 |
| 2011 | 1 | 1 | 2 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 3 | 1 | 4 |
| 2017 | 1 | 2 | 3 |
| 2018 | 1 | 0 | 1 |
| 2019 | 0 | 3 | 3 |
| 2020 | 1 | 3 | 4 |
| 2021 | 0 | 3 | 3 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 3 | 3 |
| 2024 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Insulin Infusion Systems" by people in Profiles.
-
Psychosocial outcomes with the Omnipod? 5 Automated Insulin Delivery System in caregivers of very young children with type 1 diabetes. Diabetes Obes Metab. 2024 Dec; 26(12):5569-5579.
-
Diabetes Technology Meeting 2023. J Diabetes Sci Technol. 2024 Sep; 18(5):1208-1244.
-
Glycemic Outcomes Persist for up to 2 Years in Very Young Children with the Omnipod? 5 Automated Insulin Delivery System. Diabetes Technol Ther. 2024 Jun; 26(6):383-393.
-
Real-World Evidence of Omnipod? 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes. Diabetes Technol Ther. 2024 Aug; 26(8):514-525.
-
Two Years with a Tubeless Automated Insulin Delivery System: A Single-Arm Multicenter Trial in Children, Adolescents, and Adults with Type 1 Diabetes. Diabetes Technol Ther. 2024 Jan; 26(1):11-23.
-
The Evolution of Diabetes Technology - Options Toward Personalized Care. Endocr Pract. 2023 Aug; 29(8):653-662.
-
Diabetes Technology Meeting 2022. J Diabetes Sci Technol. 2023 07; 17(4):1085-1120.
-
Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical Trial. Diabetes Care. 2022 08 01; 45(8):1907-1910.
-
Hybrid Closed-Loop Systems and Glycemic Outcomes in Children and Adults With Type 1 Diabetes: Real-World Evidence From a U.S.-Based Multicenter Collaborative. Diabetes Care. 2022 08 01; 45(8):e118-e119.
-
Clinical and Demographic Factors Associated With Diabetic Retinopathy Among Young Patients With Diabetes. JAMA Netw Open. 2021 09 01; 4(9):e2126126.